Diversifying precision cancer diagnostics and treatments
3.3%
odds of being acquired in the next two years
0.5× the average (6.8%)
#4285 of 4,339 active YC companies · top 100%
Team of 16 · Accra, Greater Accra Region, Ghana
Raises the odds
Nothing stands out.
Lowers the odds
↓ industry: Healthcare
↓ tag: Biotech
↓ sector: Diagnostics
From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.
Signals brief
ExitOdds reads Yemaachi Biotechnology's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.
Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.